Company Explorer
Trend Explorer
Tree map
Stacked
Network
Map
Scatter
Exports In 2022, Italy exported $11.8B in Vaccines, blood, antisera, toxins and cultures, making it the 7th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most exported product in Italy. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Italy are: United States ($2.66B), Netherlands ($2.62B), Belgium ($1.4B), Germany ($1.11B), and Poland ($616M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Italy between 2021 and 2022 were United States ($755M), Netherlands ($522M), and Poland ($235M).
Imports In 2022, Italy imported $12.1B in Vaccines, blood, antisera, toxins and cultures, becoming the 8th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Italy. Italy imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($4.13B), Belgium ($2.08B), United States ($1.36B), Switzerland ($1.02B), and Netherlands ($987M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Italy between 2021 and 2022 were South Korea ($240M), Belgium ($204M), and Germany ($157M).
COMPANIES In 2023, leading companies such as were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Italy to the United States.
